Loxapine to control agitation during weaning from mechanical ventilation

Area of Science:

• Critical Care Medicine
• Pharmacology

Background:

• Agitation can prolong mechanical ventilation (MV) weaning.
• Loxapine is known to manage agitation without impairing spontaneous breathing.

Purpose of the Study:

• To investigate if loxapine reduces the duration of MV weaning in agitated patients.
• To assess the efficacy of loxapine in facilitating ventilator liberation.

Main Methods:

• A multicenter, double-blind, placebo-controlled, randomized trial was conducted.
• Patients exhibiting agitation (Richmond Agitation-Sedation Scale score ≥ 2) post-sedation withdrawal were randomized to loxapine or placebo.
• The primary endpoint was time to successful extubation.

Main Results:

• The trial was stopped early due to slow enrollment after 102 patients.
• Median time to extubation was 3.2 days for loxapine vs. 5 days for placebo (not statistically significant).
• Resumption of sedation within 24 hours was significantly lower in the loxapine group (17% vs. 44%).

Conclusions:

• Loxapine did not significantly shorten the duration of mechanical ventilation weaning in this study.
• Loxapine demonstrated a benefit by reducing the need to restart sedation in agitated patients undergoing weaning.